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General anaesthesia is associated with hypothermia, oxidative
stress, and immune depression. Uncoupling Protein (UCP2) is a
member of the mitochondrial carrier family present in many organs
including the spleen, the lung and the brain. A role of UCP2 in the
activation of the inﬂammatory/immune cells, in the secretion of
hormones, and in the excitability of neurons by regulating the
production of reactive oxygen species has been discussed. Because of
the side effects of anaesthesia, we aimed to question the expression
and the function of UCP2 during anaesthesia. Induction of anaesthesia
with ketamine (20 mg/kg) or isoﬂurane (3.6 %) and induction of
sedation with the α2 adrenergic receptor agonist medetomidine
(0.2 mg/kg) stimulated inﬁltration of immune cells in the lung and
increased UCP2 protein content in the lung, in both immune and non-
immune cells. UCP2 content in the lung inversely correlated with
body temperature decrease induced by medetomidine treatment.
Challenge of the Ucp2−/− mice with isoﬂurane and medetomidine
revealed an earlier behavioral recovery phenotype. Transponder
analysis of body temperature and activity showed no difference
between Ucp2−/− and control mice in basal conditions. However,
upon an acute decrease of body temperature induced by med-
etomidine, Ucp2−/− mice exhibited increased locomotion activity.
Together, these results show that UCP2 is rapidly mobilized during
anaesthesia and sedation in immune cells, and suggest a role of UCP2
in locomotion.
doi:10.1016/j.bbabio.2012.06.116
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The physiological functions of UCP2 and UCP3 are still not
established. However, extensive evidence supports the idea that these
mitochondrial carrier proteins are involved in the control of reactive
oxygen species (ROS) generation [1, 2]. Superoxide and the lipid
peroxidation product hydroxynonenal have been shown to induce
proton leak through UCPs [3, 4]. Since proton leak has the potential to
modulate ROS generation, this suggests the existence of a feedback loop
between ROS and proton leak mediated by UCPs [5]. Our aim was to
examine the effect of hydrogen peroxide (H2O2) on UCP3 expression
levels, the signalling pathways involved and the protective role
of UCP3 against oxidative damage in HL-1 mouse cardiac muscle
cells. Both UCP3 mRNA and protein signiﬁcantly increased after 3 h
treatment with H2O2 (0.3 mM), as determined by quantitative PCR
and immunoblot, respectively. Likewise, H2O2 addition increased the
nuclear accumulation of the antioxidant transcription factor Nrf2
(NF-E2-related factor 2), an essential regulator of the cellular redox
homeostasis. Nrf2 interference by siRNA prevented H2O2-mediated
UCP3 induction, and increased dichloroﬂuorescein diacetate (DCF-
DA) ﬂuorescence detection by ﬂow cytometry, indicating an increase
in ROS levels. ChIP assays allowed the identiﬁcation of an antioxidant
response element (ARE) within the UCP3 promoter that bound
Nrf2 following H2O2 treatment. Cell death was determined by ﬂow
cytometry using propidium iodide (PI) ﬂuorescence. H2O2 treatment
induced cell death only at 24 h compared to untreated HL-1 cells.
However, both siUCP3 and siNrf2 cells, showed an earlier increase on
H2O2-induced PI ﬂuorescence. Our results suggest that H2O2 treat-
ment enhances UCP3 expression via Nrf2 in cardiac cells, and that this
increase promotes survival in oxidatively challenged cells.
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In brown adipose tissue (BAT), uncoupling protein 1 (UCP1) is the
central component of non-shivering thermogenesis that provides heat
to defend body temperature in the face of low ambient temperatures.
UCP1 facilitates a proton ﬂux across themitochondrial innermembrane
thereby uncoupling respiration from ATP synthesis. In the resting state
purine di- and triphosphate nucleotides (GDP, GTP, ADP, ATP) repress
UCP1 activity, while fatty acids liberated upon adrenergic activation
overcome this inhibition and activate UCP1 upon cold exposure. So far,
cold induced alterations in cellular nucleotide concentration are not
thought to play a role in UCP1 regulation. In BAT, guanosine mono-
phosphate reductase (GMPR) is strongly upregulated upon cold
exposure on both the mRNA and the protein level. This enzyme
catalyzes the reaction of GMP back to the common presurcor of both
guanosine and adenosine nucleotides, inosine monophosphate (IMP).
We aimed to unravel a possible role of GMPR and an altered purine
nucleotide metabolism in the regulation of UCP1 activity.
Concordant with its molecular function, forced expression of GMPR
in a heterologous expression system led to a shift in the ratio between
adenosine and guanosine nucleotides without a disturbance in
overall cellular energy balance. In the presence of UCP1, however,
theGMPRmediated A/G shiftwas accompanied by a loss in triphosphate
nucleotides indicating an impaired energy supply. Furthermore, in the
presence of both UCP1 and GMPR cells displayed an increased basal and
fatty acid induced proton leak respiration. Both ﬁndings imply that the
enzymatic action of GMPR leads to an increased UCP1-mediated proton
leak by altering purine nucleotide concentrations.
doi:10.1016/j.bbabio.2012.06.118
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Uncoupling protein 3 (UCP3) is a mitochondrial carrier with
multiple assigned functions including the transport of protons to
reduce ROS formation and modulate calcium homeostasis, the export
of excess free fatty acids or lipid radicals and the transport of chloride
or pyruvate. UCP3 is expressed but differentially regulated in skeletal
muscle (SKM) and brown adipose tissue (BAT). Initial characteriza-
tion of the basal promoter revealed binding sites for PPARγ, MyoD
and thyroid receptor but the underlying mechanisms differentiating
gene expression between BAT and SKM are not known to date. Our
group identiﬁed an intronic element required for Ucp3 expression in
BAT. Subsequently a PPAR response element (PPRE) in juxtaposition
of our intronic element was found.
Using band shift assays, RNA interference and reporter gene assays
we demonstrated SP1/SP3 binding to our intronic element in two
brown adipocyte cell lines. Inhibition of SP factor DNA binding either
by site directed mutagenesis or mithramycine treatment abolished
PPAR agonist activation of reporter gene constructs. Selective deletion
of the known PPREs revealed that the intronic PPRE next to our SP
binding site is sufﬁcient and required for PPAR agonist activation.
Transactivationwas solely conveyed by the PPARγ agonist rosiglitazone
while neither PPARα nor PPARδ agonists were of relevance in our
system. Finally stepwise deletions covering the whole ﬁrst intron
assisted by bioinformatics revealed a putative MyoD binding site right
next to the dual SP/PPAR element.
Using the very same reporter constructs, PPAR stimulation,
regardless of PPAR subtype, was not able to activate our reporter
gene constructs in C2C12 cells. This is well in line with data from SKM
or C2C12 cells where mutation of the SP1/3 element had no effect on
UCP3 expression. As published data demonstrate that endogenous
UCP3 mRNA expression can be induced by PPARγ agonists in those
cells, we conclude that PPAR action in SKM, in contrast to BAT,
is neither mediated by the intronic PPRE nor by the PPRE in the core
promoter.
Taken together, we propose a complex enhancer region located
within the ﬁrst intron. This module, consisting of at least SP, PPAR
and MyoD binding sites, does not only confer the responsiveness of
UCP3 to PPARγ stimulation in BAT but also differentiates regulation of
expression between skeletal muscle and brown adipose tissue.
doi:10.1016/j.bbabio.2012.06.119
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We tested a hypothesis that reactive oxygen species (ROS)-
dependent activation of mitochondrial phospholipases leads to an
increase in respiration and to more intensive attenuation of
mitochondrial ROS production due to UCP2-dependent uncoupling.
This was tested on the model of pancreatic β-cells, INS-1E cells, by
using the loss-of-function approach through UCP2 silencing. Oxygen
consumption was assayed in intact INS-1E cells under varying levels
of glucose after overnight incubation in low glucose (3 mM). Glucose
addition exhibited a steady increase in respiration which was further
stimulated by sub-millimolar concentrations of tert-butyl hydroper-
oxide (TBHP, 0.25 – 1 mM). The effect of TBHP was signiﬁcantly lower
in UCP2-silenced cells than in control cells. The TBHP-induced
respiration increase [1] was fully inhibited by (R)-bromoenol lactone
((R)-BEL, 10 – 50 μM), a selective inhibitor of phospholipase iPLA2γ,
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